The Rise and Fall of Isotonitazene and Brorphine: Two Recent Stars in the Synthetic Opioid Firmament
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Synthetic opioids constitute one of the fastest-growing groups of new psychoactive substances (NPS) worldwide. With fentanyl analogues being increasingly controlled via classwide scheduling, many non-fentanyl-related opioids are now emerging on the recreational opioid market, rendering the landscape highly complex and dynamic. While new compounds are entering the supply in rapid and unpredictable manners, some recent patterns have become apparent. Many of these newly emerging opioids are being pirated from early patent literature and/or research papers, synthesized and sold online through various channels. Burdened by the identification of every newly emerging drug, many toxicology labs struggle to keep up. Moreover, by the time a ‘new’ drug is controlled via legislative measures, illicit drug markets will have already adapted and diversified as manufacturers work to avoid the restricted product(s). Hence, the typical life cycle of an NPS opioid is generally short (less than 6 months to 1 year), with only a few drugs escalating to significant numbers of detections. In this review, we summarize the key events in the emergence, rise and subsequent decline of two non-fentanyl opioids—isotonitazene and brorphine. These two opioids sequentially dominated the NPS opioid market in 2019 and 2020. Both isotonitazene and brorphine remained in circulation for over a year, each contributing to hundreds of deaths and adverse events. By detailing the life cycles of these opioids from their earliest synthesis as described in scientific literature to their subsequent rise and fall on recreational markets, this review illustrates the new characteristic life cycle of synthetic opioids in the ‘post-fentanyl-analogue’ era.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
World Health Organization Technical Report Series
(1972) · Journal of AOAC INTERNATIONAL · doi:10.1093/jaoac/55.3.666 · Cited by 917
Fentanyl, fentanyl analogs and novel synthetic opioids: A comprehensive review
Armenian, P., Vo, K. T., Barr-Walker, J., & Lynch, K. L. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.10.016 · Cited by 710
The triple wave epidemic: Supply and demand drivers of the US opioid overdose crisis
Ciccarone, D. (2019) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2019.01.010 · Cited by 677
Kawamoto, H., Ozaki, S., Itoh, Y., Miyaji, M., Arai, S., Nakashima, H., Kato, T., Ohta, H., & Iwasawa, Y. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm990517p · Cited by 204
Vandeputte, M. M., Van Uytfanghe, K., Layle, N. K., St. Germaine, D. M., Iula, D. M., & Stove, C. P. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00064 · Cited by 161
Self-citationPasin, D., Cawley, A., Bidny, S., & Fu, S. (2017) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-017-0441-4 · Cited by 150
Isotonitazene Quantitation and Metabolite Discovery in Authentic Forensic Casework
Krotulski, A. J., Papsun, D. M., Kacinko, S. L., & Logan, B. K. (2020) · Journal of Analytical Toxicology · doi:10.1093/jat/bkaa016 · Cited by 146
Self-citationDARK Classics in Chemical Neuroscience: Etonitazene and Related Benzimidazoles
Ujváry, I., Christie, R., Evans-Brown, M., Gallegos, A., Jorge, R., de Morais, J., & Sedefov, R. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00037 · Cited by 141
Blanckaert, P., Cannaert, A., Van Uytfanghe, K., Hulpia, F., Deconinck, E., Van Calenbergh, S., & Stove, C. (2020) · Drug Testing and Analysis · doi:10.1002/dta.2738 · Cited by 116
Self-citationKrotulski, A. J., Papsun, D. M., Walton, S. E., & Logan, B. K. (2021) · Drug Testing and Analysis · doi:10.1002/dta.3115 · Cited by 91
Self-citation
Research works printed but not linked: 13
- UNODC, 2021, Booklet 2: Global Overview of Drug Demand and Drug Supply
- UNODC, 2019, Understanding the global opioid crisis
- UNODC, 2020, The growing complexity of the opioid crisis
- Hoffmann, 1960, Benzimidazoles
- Hoffmann, 1959, Verfahren zur Herstellung analgetisch wirksamer Benzimidazole
- World Health Organization, 1961, Expert committee on addiction-producing drugs, 1
- EMCDDA, 2020, EMCDDA Initial Report on the New Psychoactive Substance N,N-diethyl-2,4-(1-methylethoxy)phenylmethyl-5-nitro-1H-benzimidazole-1-ethanamine (Isotonitazene)
- Krotulski, 2019, Potent Synthetic Opioid - Isotonitazene - Recently Identified in the Midwestern United States
- EMCDDA, 2019, EMCDDA Operating Guidelines for the European Union Early Warning System on New Psychoactive Substances
- World Health Organization, 2020, 43rd Expert Committee on Drug Dependence (ECDD): Critical Review Report: Isotonitazene
- Janssens, 1967, Derivatives of benzimidazolinyl piperidine
- EMCDDA, 2020, EU Early Warning System Situation Report: Situation Report 1 - June 2020
- World Health Organization, 2021, 44th Expert Committee On Drug Dependence (ECDD): Substances for review 11–15 October 2021
Cited by
Montanari, E., Madeo, G., Pichini, S., Busardò, F. P., & Carlier, J. (2022) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000970 · Cited by 89
Naloxone Use in Novel Potent Opioid and Fentanyl Overdoses in Emergency Department Patients
Amaducci, A., Aldy, K., Campleman, S. L., Li, S., Meyn, A., Abston, S., Culbreth, R. E., Krotulski, A., Logan, B., Wax, P., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.31264 · Cited by 84
Self-citationVandeputte, M. M., Krotulski, A. J., Walther, D., Glatfelter, G. C., Papsun, D., Walton, S. E., Logan, B. K., Baumann, M. H., & Stove, C. P. (2022) · Archives of Toxicology · doi:10.1007/s00204-022-03276-4 · Cited by 80
Self-citationDe Vrieze, L. M., Walton, S. E., Pottie, E., Papsun, D., Logan, B. K., Krotulski, A. J., Stove, C. P., & Vandeputte, M. M. (2024) · Archives of Toxicology · doi:10.1007/s00204-024-03774-7 · Cited by 58
“1, 2), which quickly populated the NSO market and has since been implicated in hundreds of deaths worldwide, stressing the dangerous nature of this family of opioids (EMCDDA 2020; Krotulski et al. 2020; Muel-ler et al. 2021; Vandeputte et al. 2022a; Montanari et al. 2022).”
BackgroundSelf-citationNon-Fentanyl New Synthetic Opioids—An Update
Zawilska, J. B., Adamowicz, P., Kurpeta, M., & Wojcieszak, J. (2023) · Forensic Science International · doi:10.1016/j.forsciint.2023.111775 · Cited by 55
Glatfelter, G. C., Vandeputte, M. M., Chen, L., Walther, D., Tsai, M.-H. M., Shi, L., Stove, C. P., & Baumann, M. H. (2023) · Psychopharmacology · doi:10.1007/s00213-023-06451-2 · Cited by 52
Self-citationPapsun, D. M., Krotulski, A. J., & Logan, B. K. (2022) · American Journal of Forensic Medicine & Pathology · doi:10.1097/paf.0000000000000787 · Cited by 51
Self-citationDe Luca, M. A., Tocco, G., Mostallino, R., Laus, A., Caria, F., Musa, A., Pintori, N., Ucha, M., Poza, C., Ambrosio, E., et al. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109263 · Cited by 48
Vandeputte, M. M., Verougstraete, N., Walther, D., Glatfelter, G. C., Malfliet, J., Baumann, M. H., Verstraete, A. G., & Stove, C. P. (2022) · Archives of Toxicology · doi:10.1007/s00204-022-03294-2 · Cited by 44
Self-citationVandeputte, M. M., Tsai, M.-H. M., Chen, L., Glatfelter, G. C., Walther, D., Stove, C. P., Shi, L., & Baumann, M. H. (2023) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2023.109939 · Cited by 39
Self-citationAxelsson, M., Lövgren, H., Kronstrand, R., Gréen, H., & Bergström, M. A. (2022) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13786 · Cited by 38
Vandeputte, M. M., & Stove, C. P. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110470 · Cited by 36
Self-citationNitazene test strips: a laboratory evaluation
De Vrieze, L. M., Stove, C. P., & Vandeputte, M. M. (2024) · Harm Reduction Journal · doi:10.1186/s12954-024-01078-8 · Cited by 34
“…7 ), butonitazene ( 8 ), N -pyrrolidino 4’-hydroxy nitazene citrate ( 9 ), N -pyrrolidino metonitazene citrate ( 10 ), N -pyrrolidino etonitazene ( 11 ), N -pyrrolidino protonitazene ( 12 ), N -pyrrolidino isotonitazene citrate ( 13 ), N -piperidinyl 4’-hydroxy nitazene citrate ( 14 ), N…”
BackgroundSelf-citationVerveri, C., Galletto, M., Massano, M., Alladio, E., Vincenti, M., & Salomone, A. (2024) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2024.115975 · Cited by 34
Walton, S. E., Krotulski, A. J., Glatfelter, G. C., Walther, D., Logan, B. K., & Baumann, M. H. (2023) · Psychopharmacology · doi:10.1007/s00213-022-06292-5 · Cited by 33
Self-citationAwuchi, C. G., Aja, P. M., Mitaki, N. B., Morya, S., Amagwula, I. O., Echeta, C. K., & Igwe, V. S. (2023) · Journal of Chemistry · doi:10.1155/2023/5852315 · Cited by 29
Swartz, J. A., Lieberman, M., Jimenez, A. D., Mackesy‐Amiti, M. E., Whitehead, H. D., Hayes, K. L., Taylor, L., & Prete, E. (2023) · Harm Reduction Journal · doi:10.1186/s12954-023-00821-x · Cited by 28
Tsai, M.-H. M., Chen, L., Baumann, M. H., Canals, M., Javitch, J. A., Lane, J. R., & Shi, L. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00750 · Cited by 27
Norman, C., Marland, V., McKenzie, C., Ménard, H., & Nic Daéid, N. (2023) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2023.104102 · Cited by 25
Vandeputte, M. M., Persson, M., Walther, D., Vikingsson, S., Kronstrand, R., Baumann, M. H., Gréen, H., & Stove, C. P. (2022) · Archives of Toxicology · doi:10.1007/s00204-021-03207-9 · Cited by 24
Self-citationVandeputte, M. M., Vasudevan, L., & Stove, C. P. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108161 · Cited by 23
Self-citationGrafinger, K. E., Wilde, M., Otte, L., & Auwärter, V. (2021) · Forensic Science International · doi:10.1016/j.forsciint.2021.110989 · Cited by 21
De Baerdemaeker, K. S. C., Dines, A. M., Hudson, S., Sund, L. J., Waters, M. L., Hunter, L. J., Blundell, M. S., Archer, J. R. H., Wood, D. M., & Dargan, P. I. (2023) · QJM: An International Journal of Medicine · doi:10.1093/qjmed/hcac039 · Cited by 21
Salomone, A., Galletto, M., Massano, M., Corcia, D. D., Palamar, J. J., & Vincenti, M. (2023) · Journal of Forensic Sciences · doi:10.1111/1556-4029.15348 · Cited by 21
Vandeputte, M. M., Bilel, S., Tirri, M., Corli, G., Bassi, M., Layle, N. K., Fantinati, A., Walther, D., Iula, D. M., Baumann, M. H., et al. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110113 · Cited by 19
Self-citationCurtis, B., Lawes, D. J., Caldicott, D., & McLeod, M. D. (2025) · Drug Testing and Analysis · doi:10.1002/dta.3910 · Cited by 19
Interpol Review of Drug Analysis 2019-2022
Love, D., & Jones, N. S. (2023) · Forensic Science International Synergy · doi:10.1016/j.fsisyn.2022.100299 · Cited by 19
Synthetic Benzimidazole Opioids: The Emerging Health Challenge for European Drug Users
Di Trana, A., Pichini, S., Pacifici, R., Giorgetti, R., & Busardò, F. P. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.858234 · Cited by 18
Gao, G., Yang, S., Wang, X., Xiang, P., Ma, L., Yan, F., & Shi, Y. (2025) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2025.116707 · Cited by 16
Grigoryev, A., Kavanagh, P., Dowling, G., & Rodin, I. (2023) · Journal of Analytical Toxicology · doi:10.1093/jat/bkac001 · Cited by 16
Lee, J. C., Park, H., Eubanks, L. M., Ellis, B., Zhou, B., & Janda, K. D. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01967 · Cited by 15
Magny, R., Schiestel, T., M’Rad, A., Lefrère, B., Raphalen, J.-H., Ledochowski, S., Labat, L., Mégarbane, B., & Houzé, P. (2025) · Metabolites · doi:10.3390/metabo15060371 · Cited by 14
“Following regulatory controls, isotonitazene was substituted in the market with metonitazene in 2020 and recently with protonitazene [5,7,8].”
InfluentialPlasma drug screening using paper spray mass spectrometry with integrated solid phase extraction
Zimmerman, H., Ren, G., Dowling, S., Warren, C., Rusyniak, D. E., Avera, R., & Manicke, N. E. (2024) · Drug Testing and Analysis · doi:10.1002/dta.3687 · Cited by 14
Interpol review of toxicology 2019–2022
Cheng, J. Y.-K., Hui, J. W.-S., Chan, W.-S., So, M., Hong, Y.-H., Leung, W.-T., Ku, K.-W., Yeung, H. S., Lo, K.-M., Fung, K.-M., et al. (2022) · Forensic Science International Synergy · doi:10.1016/j.fsisyn.2022.100303 · Cited by 12
Liu, C., Huang, B., Hua, Z., Jia, W., & Zhi‐yu, L. (2025) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.10030 · Cited by 11
Discriminative stimulus and antinociceptive effects of sixteen nitazene analogs in rodents
Gatch, M. B., Hill, R. D., Sundar, M., & Shetty, R. A. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110416 · Cited by 11
Florou, D., Vlachou, T., Sakkas, V. A., & Boumba, V. A. (2022) · Journal of Xenobiotics · doi:10.3390/jox12040025 · Cited by 11
Fluorofentanyl and novel synthetic opioids in accidental overdose deaths
Yu, J., Diekhans, K., Tsang, A., & Rodda, L. N. (2024) · Journal of Analytical Toxicology · doi:10.1093/jat/bkae062 · Cited by 11
The challenge of New Psychoactive Substances - a technical update
Sutcliffe, O. B., Crean, C., Raithelhuber, M., & Tettey, J. N. A. (2024) · e-space (Manchester Metropolitan University) · Cited by 11
Nazdrajić, E., Rickert, D. A., & Pawliszyn, J. B. (2023) · Analytical Chemistry · doi:10.1021/acs.analchem.3c04354 · Cited by 11
Vandeputte, M. M., Walton, S. E., Shuda, S. A., Papsun, D. M., Krotulski, A. J., & Stove, C. P. (2023) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-023-04722-7 · Cited by 10
Self-citationEvaluation of enzyme-linked immunosorbent assay screening kits for the detection of nitazene analogs
Pacana, A. L., & Skillman, B. N. (2025) · Journal of Forensic Sciences · doi:10.1111/1556-4029.70052 · Cited by 9
Are the NPS commonly used? An extensive investigation in Northern Italy based on hair analysis
Calvetti, C., Salomone, A., Verzeletti, A., Nardo, F. D., Begni, P. M. G., & Vezzoli, S. (2023) · Journal of Analytical Toxicology · doi:10.1093/jat/bkad040 · Cited by 9
Cibulsky, S. M., Wille, T., Funk, R., Sokolowski, D., Gagnon, C., Lafontaine, M., Brevett, C. A. S., Jabbour, R., Cox, J., Russell, D. R., et al. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1158479 · Cited by 8
Grafinger, K. E., Weinmann, W., Pasin, D., Gréen, H., Stove, C. P., Schöning, V., & Hammann, F. (2026) · Forensic Science International · doi:10.1016/j.forsciint.2026.112883 · Cited by 7
Self-citationYang, L., Zheng, S., Hou, A., Wang, S., Zhang, J., Yu, H., Wang, X., & Lan, W. (2022) · Medicine · doi:10.1097/md.0000000000031009 · Cited by 7
Behavioural Effects and Naloxone Effectiveness With New Synthetic Opioids
Nielsen, S., Silva, J. P., Jones, J. D., Krotulski, A., Poovendran, D., Muzangizi, D., Forte, G., White, J., & Comer, S. D. (2026) · Drug and Alcohol Review · doi:10.1111/dar.70040 · Cited by 6
Self-citationPhelps, C., Hardwick, E. K., Couch, A. N., & Davidson, J. T. (2025) · Journal of Forensic Sciences · doi:10.1111/1556-4029.70084 · Cited by 6
“Likewise, the life cycle of NSOs can be as short as 6–18 months, which further complicates their identification [ 16 ].”
Brorphine and Its Analogues: Pharmacology, Toxicology, and Biomonitoring
Marchei, E., Graziano, S., Pichini, S., & Farré, M. (2026) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000001446 · Cited by 6
Isotonitazene: a new synthetic opioid in the UK
Nahar, L. K., Andrews, R., & Paterson, S. (2021) · BMJ · doi:10.1136/bmj.n3143 · Cited by 6
Detecting novel psychoactive substances around the world
Salomone, A., & Vincenti, M. (2024) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000939 · Cited by 6
New Synthetic Opioids: What Do We Know About the Mutagenicity of Brorphine and Its Analogues?
Lenzi, M., Gasperini, S., Bilel, S., Corli, G., Rombolà, F., Hrelia, P., & Marti, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26115084 · Cited by 6
Hataoka, K., Hojo, M., Nomura, S., Nakagawa, Y., Kawai, A., Nakamura, M., Ikushima, K., Alexander, D. B., Suzuki, J., Suzuki, T., et al. (2025) · The Journal of Toxicological Sciences · doi:10.2131/jts.50.33 · Cited by 5
Ferreira, C. F., Antunes, A. M. M., Gaspar, H., & Caldeira, M. J. (2025) · Forensic Chemistry · doi:10.1016/j.forc.2025.100696 · Cited by 5
Tomiyama, K.-I., & Funada, M. (2025) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2025.117361 · Cited by 4
Dutkiewicz, D., Wilson, H. H., Jiranantakan, T., Chisholm, P., Fatema, K., & Hardy, M. (2026) · Drug and Alcohol Review · doi:10.1111/dar.70104 · Cited by 4
Toxicological aspects of emerging nitazene analogues as a new threat to the synthetic drug landscape
Martins, J. N., dos Santos, B. P., & Arbo, M. D. (2026) · Discover Toxicology · doi:10.1007/s44339-026-00050-4 · Cited by 4
Baumann, M. H., Glatfelter, G. C., & Vandeputte, M. M. (2026) · Neuropharmacology · doi:10.1016/j.neuropharm.2026.110913 · Cited by 4
Self-citationTarget Analysis of Synthetic Opioids in Blood and Urine
Rodda, L. N. (2022) · Methods in pharmacology and toxicology · doi:10.1007/978-1-0716-2605-4_4 · Cited by 4
Jones, A. W. (2023) · Journal of Analytical Toxicology · doi:10.1093/jat/bkad080 · Cited by 3
Synthetic Opioids as New Psychoactive Substances (NPS)
Cruz, S. L., & Martín-del-Campo, R. (2022) · Springer eBooks · doi:10.1007/978-3-031-09936-6_16 · Cited by 3
García, R. G., & López-Briz, E. (2023) · Revista Española de Drogodependencias · doi:10.54108/10040 · Cited by 3
Negrault, N., Puech, B., Guyon, J., Daveluy, A., Bastard, S., Mete, D., & Maillot, A. (2025) · Annales de Toxicologie Analytique · doi:10.1016/j.toxac.2025.01.096 · Cited by 2
Kashindye, R. C., Yadav, D., & Yadav, R. (2026) · Journal of Forensic and Legal Medicine · doi:10.1016/j.jflm.2026.103069 · Cited by 2
In Vitro Cytotoxic and Genotoxic Evaluation of Nitazenes, a Potent Class of New Synthetic Opioids
Rombolà, F., Bartoletti, S., Bilel, S., Hrelia, P., Marti, M., & Lenzi, M. (2025) · Journal of Xenobiotics · doi:10.3390/jox15060203 · Cited by 2
Lahmy, R., Hübner, H., Gmeiner, P., & König, B. (2024) · ChemPhotoChem · doi:10.1002/cptc.202400022 · Cited by 2
Tishion, P., Derrick, D., Sorrentino, J., & Cooper, G. A. A. (2025) · Journal of Forensic Sciences · doi:10.1111/1556-4029.70196 · Cited by 2
Development of a Method to Detect Nitazenes in Seized Drug Samples
Bergman, E. N. (2024) · eScholarship (California Digital Library) · Cited by 2
Jadreško, D., Vianello, R., & Jovanović, I. N. (2026) · Electrochimica Acta · doi:10.1016/j.electacta.2026.148341 · Cited by 2
Deligianni, E., Arillotta, D., Vento, A. E., Corkery, J., Papazisis, G., Goulas, A., Lione, L. A., & Schifano, F. (2025) · Pharmaceuticals · doi:10.3390/ph19010017 · Cited by 1
Wissenbach, D., Wissenbach, D. K., & Maurer, H. H. (2024) · Comprehensive analytical chemistry · doi:10.1016/bs.coac.2024.10.013 · Cited by 1
Hair Analysis to Understand the Diffusion of New Psychoactive Substances
Salomone, A. (2023) · Royal Society of Chemistry eBooks · doi:10.1039/bk9781837671946-00207 · Cited by 1
Commentary on Zhu et al .: Nitazenes—Tracking a moving target from linked United States databases
Stove, C. P., & Vandeputte, M. M. (2026) · Addiction · doi:10.1111/add.70480
Self-citationZschiesche, A., Nadler, J., Pulver, B., Scheu, M., Auwärter, V., & Hermanns‐Clausen, M. (2026) · Frontiers in Toxicology · doi:10.3389/ftox.2026.1951240
Gerona, R. R. L. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-811764-4.00005-7
Bracaglia, I., Chiodo, L., Montesano, C., Bilel, S., Bassi, M., Cocita, N., Rosa, F. D., Gregori, A., Marti, M., Marini, F., et al. (2026) · Metabolites · doi:10.3390/metabo16100770
Helfer, die in die Hölle führen können: Von Opium zu Fentanyl
Strey, K. (2025) · Chemie in unserer Zeit · doi:10.1002/ciuz.202400019
Massano, M. (n.d.) · Institutional Research Information System University of Turin (University of Turin)
Toolkit on key responses to synthetic opioids
Abel‐Ollo, K., Andree, R., Colman, C., Kivimets, K., Kools, J.-P., Kurbatov, A., Moazen, B., Oja, M., Pattyn, R., Gayo, R. P., et al. (2022) · STM:n Hallinnonalan avoin julkaisuarkisto (Julkari)
Bhullar, M. K., Gilson, T. P., & Boggs, P. D. (2021) · Journal of Forensic Sciences · doi:10.1111/1556-4029.14959
Vpliv nekaterih novih sintetičnih kanabinoidov in katinonov na izbrane ionske kanale v srcu
Blagajac, I. (2023) · Repository of the University of Ljubljana (University of Ljubljana)
Mass Spectrometry Assay Development for Small Molecule Drug Therapies and Drugs of Abuse
Zimmerman, H. (2024) · IUScholarWorks (Indiana University) · doi:10.7912/cb1r-9g76
Metadata
- Authors
- Vandeputte, M. M., Krotulski, A. J., Papsun, D. M., Logan, B. K., & Stove, C. P.
- Affiliations
- Ghent University (BE)
- Fredric Rieders Family Foundation (US)
- NMS Labs, 200 Welsh Rd, Horsham, PA 19044, USA
- Corresponding author
- Stove, Christophe P
- Venue
- Journal of Analytical Toxicology
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-07-31
- Volume
- 46
- Issue
- 2
- Pages
- 115-121
- ISSN
- 0146-4760 (ISSN-L)
- 1945-2403
- OpenAlex
- W3180270048
- Semantic Scholar
- eed9ec64ef71540e7665970e3bbbb48d14604f23
- Cited by
- 71
- References
- 28
- Citations by year
- 2026: 5 · 2025: 17 · 2024: 11 · 2023: 17 · 2022: 18 · 2021: 3
- FWCI
- 7.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Journal of Analytical Toxicology (publishedVersion)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- Funders
- Fonds Wetenschappelijk Onderzoek (3S038719, G069419N)
- Bijzonder Onderzoeksfonds UGent (01J15517)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Social Sciences › Law › Cybercrime and Law Enforcement Studies
- Keywords
- isotonitazene, synthetic opioids, new psychoactive substances, drug life cycle, illicit drug markets, opioid-related deaths, opioid adverse events, drug scheduling
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.